MESOMesoblast Limited
$12.27-32% 1Y
$12.27
$11.9552 weeks$20.96
Is the price fair?
What MESO's price assumes
Mesoblast Limited did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 747× revenue.
747
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 11.5
Price / book · as of 2023-Q2
- EV / sales
- 752
EV / sales
Details›
- Price / bookas of 2023-Q2
- 11.5
- EV / salesas of 2023-Q2
- 752
- Market capitalisation129.7 million shares, counted Jun 30, 2026
- $1.59B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.